ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

141–160 of 298 studies

E2 ModerateCohortPEM not requiredLongitudinal

Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study.

Pedersen, Maria, Asprusten, Tarjei Tørre, Godang, Kristin et al.·Brain, behavior, and immunity·2019

This study followed 200 teenagers who had an acute Epstein-Barr virus (EBV) infection to see which factors predicted who would develop lasting fatigue six months later. Researchers measured many baseline characteristics including pain sensitivity, mood, memory, physical activity level, and blood markers like vitamin B12 and inflammation levels. They found that fatigue six months after EBV was most strongly predicted by things like sensory sensitivity, pain, anxiety, and how active the teenager was—rather than by immune system markers alone.

Evidence Atlas

Evidence browser

Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study.

Artificial intelligence based discovery of the association between depression and chronic fatigue syndrome.

Multidimensional Comparison of Cancer-Related Fatigue and Chronic Fatigue Syndrome: The Role of Psychophysiological Markers.

Associations between clinical symptoms, plasma norepinephrine and deregulated immune gene networks in subgroups of adolescent with Chronic Fatigue Syndrome.

A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy.

Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

A laboratory approach for characterizing chronic fatigue: what does metabolomics tell us?

Rethinking ME/CFS Diagnostic Reference Intervals via Machine Learning, and the Utility of Activin B for Defining Symptom Severity.

Structural brain changes versus self-report: machine-learning classification of chronic fatigue syndrome patients.

The UK ME/CFS Biobank: A Disease-Specific Biobank for Advancing Clinical Research Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME).

Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection.

Hand Grip Strength as a Clinical Biomarker for ME/CFS and Disease Severity.

Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology.

Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.

Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.

The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.

Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study.

Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.

Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research